Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Peng

Showing results (1171-1180 of 2,125) with videos related to

Pageof 213
Sort By:
ACS Omega|June 13, 2022
PVP-Modified Multifunctional Bi<sub>2</sub>WO<sub>6</sub> Nanosheets for Enhanced CT Imaging and Cancer RadiotherapyYifan Hao, Bo Peng, Chao Si, et al.
World Journal of Gastroenterology|March 31, 2011
TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysisDe-Ke Jiang, Lei Yao, Wen-Zhang Wang, et al.
Scientific Reports|July 15, 2015
Optomechanically-induced transparency in parity-time-symmetric microresonatorsH Jing, Şahin K Özdemir, Z Geng, et al.
Virulence|January 18, 2018
Boosted TCA cycle enhances survival of zebrafish to Vibrio alginolyticus infectionMan-Jun Yang, Zhi-Xue Cheng, Ming Jiang, et al.
Human Brain Mapping|February 20, 2018
Latent source mining in FMRI via restricted Boltzmann machineXintao Hu, Heng Huang, Bo Peng, et al.
Chembiochem : a European Journal of Chemical Biology|February 22, 2018
MSN-on-a-Chip: Cell-Based Screenings Made Possible on a Small-Molecule Microarray of Native Natural ProductsBo Peng, Changmin Yu, Shubo Du, et al.
Plos Pathogens|August 26, 2022
Succinate and inosine coordinate innate immune response to bacterial infectionMing Jiang, Zhuang-Gui Chen, Hui Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2011
Clinical consequences of MRI activity in treated multiple sclerosisDiego Cadavid, Soyeon Kim, Bo Peng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 19, 2022
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System DiseasesMeihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Chinese Medicine|April 3, 2022
Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trialXuedong An, Bo Peng, Xiaodong Huang, et al.
Pageof 213

Showing results (1171-1180 of 2,125) with videos related to

Sort By:
Pageof 213
ACS Omega|June 13, 2022
PVP-Modified Multifunctional Bi<sub>2</sub>WO<sub>6</sub> Nanosheets for Enhanced CT Imaging and Cancer RadiotherapyYifan Hao, Bo Peng, Chao Si, et al.
World Journal of Gastroenterology|March 31, 2011
TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysisDe-Ke Jiang, Lei Yao, Wen-Zhang Wang, et al.
Scientific Reports|July 15, 2015
Optomechanically-induced transparency in parity-time-symmetric microresonatorsH Jing, Şahin K Özdemir, Z Geng, et al.
Virulence|January 18, 2018
Boosted TCA cycle enhances survival of zebrafish to Vibrio alginolyticus infectionMan-Jun Yang, Zhi-Xue Cheng, Ming Jiang, et al.
Human Brain Mapping|February 20, 2018
Latent source mining in FMRI via restricted Boltzmann machineXintao Hu, Heng Huang, Bo Peng, et al.
Chembiochem : a European Journal of Chemical Biology|February 22, 2018
MSN-on-a-Chip: Cell-Based Screenings Made Possible on a Small-Molecule Microarray of Native Natural ProductsBo Peng, Changmin Yu, Shubo Du, et al.
Plos Pathogens|August 26, 2022
Succinate and inosine coordinate innate immune response to bacterial infectionMing Jiang, Zhuang-Gui Chen, Hui Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 27, 2011
Clinical consequences of MRI activity in treated multiple sclerosisDiego Cadavid, Soyeon Kim, Bo Peng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 19, 2022
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System DiseasesMeihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Chinese Medicine|April 3, 2022
Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trialXuedong An, Bo Peng, Xiaodong Huang, et al.
Pageof 213